Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Baxter International (NY:BAX)

30.90 UNCHANGED
Streaming Delayed Price Updated: 7:00 PM EDT, May 9, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Baxter International

< Previous 1 2 3 4 5 6 7 8 9
...
15 16 Next >
3 Cash-Producing Stocks in the Doghouse
A company that generates cash isn’t automatically a winner. Some businesses stockpile cash but fail to reinvest wisely, limiting their ability to expand. 
Via StockStory
Looking Into Baxter Intl's Recent Short Interest
Via Benzinga
Baxter Declares Quarterly Dividend
From Baxter International Inc.
Via Business Wire
Baxter Reports Strong Medical Devices Sales In Q1, Lifts 2025 Guidance, Stock Jumps
Baxter raised its 2025 outlook after strong Q1 results, citing robust growth in infusion therapies and advanced surgery. 
Via Benzinga
These S&P500 stocks are moving in today's pre-market session
Get insights into the top gainers and losers in the S&P500 index of Thursday's pre-market session. 
Via Chartmill
Earnings Scheduled For May 1, 2025
Via Benzinga
What Does the Market Think About Baxter Intl?
Via Benzinga
Baxter’s (NYSE:BAX) Q1: Beats On Revenue
Healthcare company Baxter International (NYSE:BAX) beat Wall Street’s revenue expectations in Q1 CY2025, with sales up 5.4% year on year to $2.63 billion. On the other hand, next quarter’s revenue... 
Via StockStory
Baxter Reports First-Quarter 2025 Results
From Baxter International Inc.
Via Business Wire
Baxter (BAX) Reports Earnings Tomorrow: What To Expect
Healthcare company Baxter International (NYSE:BAX) will be announcing earnings results tomorrow before market hours. Here’s what to look for. 
Via StockStory
Topics Artificial Intelligence World Trade
Exposures Artificial Intelligence Tariff
Baxter to Present at Bank of America Securities 2025 Health Care Conference
From Baxter International Inc.
Via Business Wire
Demystifying Baxter Intl: Insights From 4 Analyst Reviews
Via Benzinga
Baxter to Host First-Quarter 2025 Financial Results Conference Call for Investors
From Baxter International Inc.
Via Business Wire
Wondering what's happening in today's S&P500 pre-market session?
Pre-market stock analysis of S&P500 stocks on 2025-04-15: top gainers and losers in today's session. 
Via Chartmill
3 of Wall Street’s Favorite Stocks That Concern Us
Wall Street has set ambitious price targets for the stocks in this article. While this suggests attractive upside potential, it’s important to remain skeptical because analysts face institutional... 
Via StockStory
Which S&P500 stocks are moving on Friday?
Let's have a look at the top S&P500 gainers and losers in the middle of the day of today's session. 
Via Chartmill
Baxter Launches New Room Temperature Hemopatch Sealing Hemostat for Rapid and Convenient Application During Surgery
From Baxter International Inc.
Via Business Wire
What's going on in today's session: S&P500 movers
Stay updated with the movement of S&P500 stocks in today's session. Discover which S&P500 stocks are making waves on Wednesday. 
Via Chartmill
These S&P500 stocks are gapping in today's session
Stay updated with the S&P500 gap up and gap down stocks on Wednesday. Get a glimpse of the market's movement during today's session. 
Via Chartmill
Top S&P500 movers in Wednesday's pre-market session
Before the US market kicks off on Wednesday, let's examine the pre-market session and unveil the notable performers among the S&P500 top gainers and losers. 
Via Chartmill
Peering Into Baxter Intl's Recent Short Interest
Via Benzinga
Baxter to Host Annual Meeting of Stockholders in Virtual Format
From Baxter International Inc.
Via Business Wire
What's going on in today's after hours session: S&P500 movers
As the regular session of the US market on Monday comes to an end, let's delve into the after-hours session and discover the top S&P500 gainers and losers shaping the post-market sentiment. 
Via Chartmill
Baxter (BAX): Buy, Sell, or Hold Post Q4 Earnings?
Over the past six months, Baxter’s stock price fell to $36.42. Shareholders have lost 7.3% of their capital, which is disappointing considering the S&P 500 has climbed by 1.5%. This might have... 
Via StockStory
Topics Stocks
Exposures US Equities
DraftKings To Rally Over 29%? Here Are 10 Top Analyst Forecasts For Monday
Via Benzinga
What To Expect From CooperCompanies’s (COO) Q4 Earnings
Medical device company CooperCompanies (NASDAQ:COO) will be reporting results tomorrow after market close. Here’s what you need to know. 
Via StockStory
Baxter Unveils Voalte Linq Device Powered by Scotty Assistant at HIMSS25 to Advance Voice-Activated Technology in Hospital Settings
From Baxter International Inc.
Via Business Wire
Medical Devices & Supplies - Diversified Stocks Q4 Teardown: Stryker (NYSE:SYK) Vs The Rest
As the craze of earnings season draws to a close, here’s a look back at some of the most exciting (and some less so) results from Q4. Today, we are looking at medical devices & supplies - diversified... 
Via StockStory
“From Left For Dead To Loved Again” Stock Market (and Sentiment Results)…
Healthcare is the top-performing sector in the market, up 7.31% and outperforming the S&P 500 by 4.2x. Looks like the rumors of its death were indeed GREATLY EXAGGERATED. 
Via Talk Markets
Topics Stocks Stocks / Equities
Exposures US Equities
Baxter to Present at Barclays 27th Annual Global Healthcare Conference
From Baxter International Inc.
Via Business Wire
< Previous 1 2 3 4 5 6 7 8 9
...
15 16 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.